Clorox (CLX) stock has been drawing attention after recent performance figures showed mixed returns across different timeframes, prompting investors to reassess how the company’s current valuation lines up with its fundamentals and longer term track record.

At a share price of US$95.98, Clorox has seen its 30 day share price return rise 6.11%, while the 90 day share price return fell 13.84% and the 1 year total shareholder return declined 19.06%. This points to fading momentum despite a recent bounce.

If you are rethinking your portfolio after Clorox's weaker long term total shareholder return, it could be worth scanning for other ideas through the 20 top founder-led companies

With Clorox stock trading at US$95.98 alongside an indicated intrinsic discount of about 44%, the key question is whether the current price reflects a genuine margin of safety or whether the market is already factoring in future growth potential.

Most Popular Narrative: 9% Undervalued

With Clorox stock at about $95.98 versus a narrative fair value of $105.29, the current gap reflects how one widely followed framework values its future cash flows using a 7.1% discount rate.

The full-scale implementation of a modern ERP system is expected to drive long-term operational efficiencies, improving supply chain visibility, speeding innovation cycles, and reducing structural costs, which should support margin expansion and sustained earnings growth once short-term transition noise normalizes.

The core of this Clorox narrative rests on steady revenue expansion, stable profit margins, and a future earnings base that supports a higher valuation multiple than today. The real tension lies in how those assumptions balance category sluggishness with cost savings and portfolio tweaks.

Result: Fair Value of $105.29 (UNDERVALUED)

However, the Clorox narrative also hinges on categories that management describes as sluggish and on intense price and promotion pressure in areas like Glad and cat litter, which could limit both revenue and margin ambitions.

Next Steps

Given the mixed sentiment around Clorox right now, it makes sense to move quickly, review the full picture, and weigh both sides for yourself using the 4 key rewards and 2 important warning signs.

Looking for more Clorox stock ideas to compare?

If Clorox has you rethinking your next move, treat this as a cue to broaden your watchlist and pressure test your thesis against fresh ideas.

• Target reliable cash generators by reviewing companies in the 47 high quality undervalued stocks that combine quality fundamentals with prices that sit below their assessed worth.
• Prioritize stability and resilience by scanning stocks in the 68 resilient stocks with low risk scores that score well on financial strength and lower business risk.
• Hunt for future standouts early by checking the screener containing 20 high quality undiscovered gems that pair solid fundamentals with relatively low market attention.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.